OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Tulin Morcol

Tulin Morcol

President & CSO
CaPtivate Pharmaceuticals LLC
Pennsylvania Biotechnology Center
USA

Biography

Tulin Morcol, Ph.D. is the founder of CaPtivate Pharmaceuticals developing novel vaccines through its patented CaP nanoparticle-based drug/vaccine delivery and vaccine adjuvant technology. She earned her doctorate degree in Biochemical Engineering from the Virginia Polytechnic Institute and State University, Blacksburg VA. She has 20 years of research experience in academia and industry which include Department of Chemical Engineering at VA-Tech, Department of Neuroscience, Morehouse School of Medicine, Atlanta GA, and over 10 years as the Director of Preclinical Development at BioSante Pharmaceuticals, Atlanta, GA and Doylestown, PA. She is the inventor/co-inventor in numerous issued US and International patents related to CaP nanoparticle technology. Her area of expertise include protein purification, process development and scale-up, developing formulation strategies for therapeutic drugs and vaccines for non-invasive administration, and developing large scale manufacturing processes for nanoparticles.

Research

Her area of expertise include protein purification, process development and scale-up, developing formulation strategies for therapeutic drugs and vaccines for non-invasive administration, and developing large scale manufacturing processes for nanoparticles.